DG Preventive Cancer
Preventive genetic study to determine the risk of hereditary cancer development
Our preventive test for cancer
DG Preventive Cancer is a preventive genetic test that studies 86 genes related to the susceptibility to develop different types of hereditary cancer.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the Spanish Society of Medical Oncology.
The types of hereditary cancer studied with DG Preventive Cancer are:
- Colorectal
- Gastric
- Gynecological
- Prostate
- Renal
- Skin
- Retinoblastoma
- Neuroendocrine tumors
- Cancer predisposition syndromes
- EDTA blood (1x 5 ml)
- Saliva (specific Isohelix kit)
- Buccal exudate (2x sterile isopes)
- Isolated DNA (>30 ng/μl in >100 μl)
Remember to label each sample with the patient's first and last name or with the identifier used on the request form.
Prevention is key in cancer
Cancer is the second leading cause of death in the world and it is known that in up to 15% of cases there is a hereditary component.
Epidemiological data demonstrate the importance of early diagnosis for patient survival. Thus, colorectal cancer and breast cancer, for example, have five-year survivals of 14% and 30%, respectively, when diagnosed at stage IV, but which rise to 91% and 99% if diagnosed at stage I.
DG Preventive Cancer can help identify individuals with mutations in genes associated with the development of hereditary cancer, which would allow specialists to implement early preventive and follow-up measures to prevent its occurrence or to diagnose it at the earliest possible stage.
Source: CA Cancer J Clin. 2023
Who is our DG Preventive Cancer study aimed at?
- People with a family history of hereditary cancer.
- Healthy people who are concerned about their own health care and that of their family members.
- Anyone who wants to know the risk of transmitting a genetic disease to their children.
We offer the possibility of performing the genetic study from a saliva sample. For this purpose, we provide our clients with saliva collection kits, so that the patient can collect the sample comfortably at home. Each kit contains a saliva collector, collection instructions, a request form and an informed consent form.
Technical characteristics
- Whole Exome Sequencing
- SureSelect Human All Exon V8 Library
- Illumina® technology NovaSeq 6000 platform
- Average coverage 100 x - 150 x
- Bioinformatics analysis using our software Genome One
- Classification of variants according to ACMG criteria
- Analysis of SNVs, Indels and CNVs
- Samples: EDTA blood, saliva and buccal exudate.
- Delivery time: 35-45 days
Other options available
DG Preventive Cardio
DG Preventive Cardio is a preventive genetic test that analyzes 124 actionable genes associated with the risk of developing 34 inherited cardiovascular diseases.
DG Preventive Essential
DG Preventive Essential is a test that analyzes the 81 actionable genes recommended by the ACMG for study related to 37 high-incidence diseases, most of them cardiovascular diseases and cancer.
DG Preventive Premium
DG Preventive Premium is a preventive genetic test that analyzes 344 genes related to the risk of developing hereditary cardiovascular diseases, hereditary cancer and autosomal recessive or X-linked diseases.
Our DG Preventive report
- All DG Preventive reports are written in a simple way so that they can be easily understood by the patient.
- Pathogenic and Probably Pathogenic variants are reported according to the ACMG classification.
- The possible outcomes and the implication of each of them are explained in detail.
- Recommendations for the patient and family members are included.
- Information on the genes analyzed and the diseases studied is included.
DG Preventive Cancer
Preventive genetic study to determine the risk of hereditary cancer development
Our preventive test for cancer
DG Preventive Cancer is a preventive genetic test that studies 86 genes related to the susceptibility to develop different types of hereditary cancer.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the Spanish Society of Medical Oncology.
The types of hereditary cancer studied with DG Preventive Cancer are:
- Colorectal
- Gastric
- Gynecological
- Prostate
- Renal
- Skin
- Retinoblastoma
- Neuroendocrine tumors
- Cancer predisposition syndromes
Who is our DG Preventive Cancer study aimed at?
- People with a family history of hereditary cancer.
- Healthy people who are concerned about their own health care and that of their family members.
- Anyone who wants to know the risk of transmitting a genetic disease to their children.
We provide our customers with saliva collection kits, so that the patient can collect the sample with total comfort at home.
Features
- Whole Exome Sequencing
- SureSelect Human All Exon V8 Library
- Illumina® technology NovaSeq 6000 platform
- Medium coverage 100-150x
- Bioinformatics analysis using our software Genome One
- Classification of variants according to ACMG criteria
- Analysis of SNVs, Indels and CNVs
- Samples: EDTA blood, saliva and buccal exudate.
- Delivery time: 35-45 days
Other options available
DG Preventive Cardio
DG Preventive Cardio is a preventive genetic test that analyzes 124 actionable genes associated with the risk of developing 34 inherited cardiovascular diseases.
DG Preventive Essential
DG Preventive Essential is a test that analyzes the 81 actionable genes recommended by the ACMG for study related to 37 high-incidence diseases, most of them cardiovascular diseases and cancer.
DG Preventive Premium
DG Preventive Premium is a preventive genetic test that analyzes 344 genes related to the risk of developing hereditary cardiovascular diseases, hereditary cancer and recessive or X-linked monogenic diseases.
Our DG Preventive genetic report
- All DG Preventive reports are written in a simple way so that they can be easily understood by the patient.
- Pathogenic and Probably Pathogenic variants are reported according to the ACMG classification.
- The possible outcomes and the implication of each of them are explained in detail.
- Recommendations for the patient and family members are included.
- Information on the genes analyzed and the diseases studied is included.
DG Preventive Cancer
Preventive genetic study to determine the risk of hereditary cancer development
Our preventive test for cancer
DG Preventive Cancer is a preventive genetic test that studies 86 genes related to the susceptibility to develop different types of hereditary cancer.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the Spanish Society of Medical Oncology.
The types of hereditary cancer studied with DG Preventive Cancer are:
- Colorectal
- Gastric
- Gynecological
- Prostate
- Renal
- Skin
- Retinoblastoma
- Neuroendocrine tumors
- Predisposition syndromes
Features
- Whole Exome Sequencing
- SureSelect Human All Exon V8 Library
- Illumina® technology NovaSeq 6000 platform
- Medium coverage 100-150x
- Bioinformatics analysis using our software Genome One
- Classification of variants according to ACMG criteria
- Analysis of SNVs, Indels and CNVs
- Samples: EDTA blood, saliva and buccal exudate.
- Delivery time: 35-45 days
DG Preventive Report
- All DG Preventive reports are written in a simple way so that they can be easily understood by the patient.
- Pathogenic and Probably Pathogenic variants are reported according to the ACMG classification.
- The possible outcomes and the implication of each of them are explained in detail.
- Recommendations for the patient and family members are included.
- Information on the genes analyzed and the diseases studied is included.